News Articles 51 - 60 of 160
The 2018 Gilead UK and Ireland Fellowship Programme is now open for grant applications in viral hepatitis.
The aim of the Programme is to support local innovation and best practice in patient care in HIV, viral hepatitis, oncology/haematology, respiratory and invasive fungal disease.
The Programme invites applications from healthcare or allied professionals who are seeking funding for a project that aligns with the goals of the Gilead UK & Ireland Fellowship Programme.
The 2018 Viral Hepatitis Fellowship programme will support projects aligned to the theme:
Systematic HCV testing (or re-engagement of those previously diagnosed) in at-risk populations in community-based services (e.g. community pharmacy, correctional services, etc) including community-based treatment initiation.
To view the application criteria and apply visit: www.gileadgiving.co.uk , all applications must be made via the online form.
Please note that the application period will close on Friday 1 June 2018
For specific application queries, please contact the Gilead UK and Ireland Fellowship Administrators on: firstname.lastname@example.org .
Public Health England (PHE) has recently published a recovery plan on gov.uk to support re-introduction of hepatitis B vaccine in a phased approach during 2018 for lower priority groups mainly vaccinated by occ health and primary care.
View a letter from PHE here: Download PHE letter to stakeholders _hepB vaccine recovery plan 2018.pdf
The link to the recovery plan on the gov.uk website can be found > here.
Welcome to the Europe and Canada Practice to Policy® Health Awards Programme
In 2018, Intercept is excited to offer grant support to local and national projects within eligible countries across Europe and Canada. The Europe and Canada Practice to Policy® Health Awards Programme encourages the development of innovative projects which improve the lives of people with primary biliary cholangitis (PBC).
The application window is now open.
Please note that the deadline for applying is Wednesday 6 June 2018.
Visit the website here - https://www.interceptpracticetopolicy.com/eu .
Job Reference: 304-18C011
Employer: University Hospitals Birmingham NHS Foundation Trust - Medical & Dental
Location: Birmingham, Queen Elizabeth Hospital
Salary: £76,761 - £103.490
Closing Date: 31 March 2018
Applications are invited for 2 x 1.0 WTE Hepatology Consultants (10 PAs) to join the existing liver medicine team. The successful applicants will work as Transplant Physicians within the Department of Hepatology. The department consists of 14 Consultant Hepatologists (including 6 Transplant Physicians and 6 Academic Hepatologists), 3 Hepatology Fellows and 8 specialist hepatology trainees. The successful applicant will contribute to clinical service development and delivery as a member of the hepatology team, working closely with colleagues in the Liver and Hepatobiliary Unit, Interventional Radiology and Oncology.
Full details can be found on the NHS Jobs site > here.
The Advisory Committee on Clinical Excellence Awards (ACCEA) opened the 2018 awards round on Tuesday 13th February. The final closing date for applications to the ACCEA is 17:00 on Thursday 12th April.
Application for BASL support
If you would like to apply for BASL support, please complete and submit a copy of your ACCEA Application Form to BASL, along with any other supplementary CVQs as detailed below:
- Supplementary CV Questionnaire: Research & Innovation Assessment
- Supplementary CV Questionnaire: Teaching & Training Assessment
- Supplementary CV Questionnaire: Medical Leadership & Managing a High Quality Service Assessment.
Please be aware that there is a maximum number of supplementary forms that can be completed at each National Level: Bronze and Silver applicants: 1 and Gold applicants: 2. These forms are optional and it is for the applicant to decide whether using them will increase chances of success.
Full application guidance can be found on the ACCEA website including the use of the Supplementary Forms by clicking here.
In addition BASL requires a short piece to accompany your application stating why you feel you should be supported by BASL.
The deadline for applying for BASL support is 17:00 on Friday 16th March 2018.
All applications must go through the ACCEA on line system, should you need a downloadable form to send to BASL these can be found on the ACCEA website by clicking here.
As in previous years BASL are able to support colleagues directly by nomination for national Gold, Silver and Bronze awards. As a specialist society, BASL cannot make nominations for Platinum awards; this must be done through the applicant’s University/Research Body and Universities UK. BASL can however provide a citation to support an application for a Platinum award.
To apply for BASL support, please follow the steps below:
1. Send a completed ACCEA Application Form, along with a short piece as to why you feel you should be supported by BASL, to the BASL Secretariat, Judy.Hawksworth@execbs.com by 17:00 on Friday 16th March 2018.
Please understand that in fairness to all applicants, late submissions will not be considered.
2. All applicants are asked to provide the name of an individual who could write a supporting citation when submitting their application to BASL. ACCEA regard the citations provided in support of individuals as giving added value to the process. The citation MAY be stronger if it comes from outside ones institution.
3. You must submit your own application to ACCEA online by their deadline 17:00 on Thursday 12th April 2018. This is your own responsibility.
4. If you are in receipt of BASL support then BASL will upload your citation. You must ensure that your application is uploaded to the ACCEA website at least one week before the deadline - 17:00 on Thursday 5th April 2018, so that BASL has sufficient time to upload your citations onto your application on the ACCEA website.
Read the summary of the report from the first BVHG and BASL Best Practice for ODN Stakeholders Meeting which was held on the 10–11 January 2018 in Manchester on the BVHG page of the website by clicking here.
The report highlights the limitations of the current HCV treatment model, and provides suggestions on how it can be modified and improved. The report describes best practice examples for eliminating HCV for ODNs to take and adapt to work in their area. The intention is that this information will provide all ODNs with a framework to develop the 5-year plans needed to meet their CQUIN requirement, and importantly to also leave them well placed to deliver on the World Health Organisations goal of HCV elimination by 2030.
Alcohol Health Alliance - Policy and Advocacy Manager
For the Alcohol Health Alliance UK based at the Institute of Alcohol Studies
Salary £35,000 per year including London weighting
Fixed 24-month contract
A copy of the Job Description and details on how to apply can be downloaded here: Download Job Description policy manager AHA Feb 2018 with interview dates.pdf
Or viewed on the AHA website: http://ahauk.org/aha-vacancy-policy-advocacy-manager/ .
Apply for this role
To apply for this role, please send a CV and cover letter outlining how you meet the criteria to Kellie Donaldson at email@example.com .
The deadline for applications is 5pm Friday 23rd February 2018.
First interviews will be held on Wednesday 7th March 2018 and successful candidates will be invited back for final interviews on Monday 19th March 2018.
The UK Liver Pathology Group (UKLPG) was formed in 2016, evolving from the UK Liver EQA Scheme and the Liver subcommittee of the Pathology Section of the BSG, with the purpose of promoting excellence in liver histopathology services in the UK and Ireland, across all levels of specialisation, through professional collaboration in education, quality assurance and research.
The Research subcommittee aims to act as a source of histopathological advice for clinicians and scientists undertaking clinical, translational or pre-clinical research (including animal modelling), particularly those lacking local pathological support and resources.
The subcommittee welcome enquiries by email to UKLPG.Research@gmail.com .
UKLPG Research subcommittee
Dr Dina Tiniakos (Chair), Newcastle University
Prof Rob Goldin, Imperial College London
Dr Tu Vinh Luong, Royal Free London
Dr Tim Kendall, University of Edinburgh
Dr Ben Challoner, Guy's and St Thomas' NHS Foundation Trust
For details about the UKLPG, please see our website: http://www.virtualpathology.leeds.ac.uk/eqa/specialist/liver/index.php .
Download a copy of the information as a flyer here to share amongst colleagues; Download UKLPG Research subcommittee.pdf
Clinical Research Associate in Hepatology (Autoimmune Liver Disease)
Salary: £28,641 - £48,123 per annum
Closing date: 2 March 2018
Applications are invited for the post of Clinical Research Associate based in the Institute of Cellular Medicine (ICM) at Newcastle University, to pursue a programme of research in liver disease with a particular focus on Autoimmune Liver Disease. You will benefit from working in a group with an international reputation for its research and clinical practice in liver disease and from close interaction with the Stratified Medicine, Biomarkers and Therapeutics and Inflammation, Immunology and Immunotherapy themes in ICM. You will also be appointed an Honorary Registrar at Newcastle upon Tyne Hospitals NHS Foundation Trust contributing to specialist liver clinics and taking part in the out of hours tertiary liver unit on call rota. This will give you tertiary liver unit experience.
You will be expected to have some experience with audit and/or research and to be undertaking or completed higher specialist training in gastroenterology/hepatology. The key attribute, however, is enthusiasm to realise the opportunities offered by the post.
You must be in possession of MRCP or equivalent, with a valid full GMC Registration to eligible to apply.
This is a 2 year post with the potential to extend to a third year.
To apply, please visit the Newcastle University vacancies website.
The UK Obstetric Surveillance System (UKOSS) is collecting data during pregnancy for women with Cirrhosis who become pregnant. This is an attempt to gather data on both numbers and outcomes of women with Pregnancy and Chronic Liver Disease in the UK.
The lead investigators are Professor Cath Williamson and Professor Michael Heneghan.
The ask from Hepatologists & BASL Membership is to let patients know who are pregnant to ask their local Obstetric service to include them in the data collection for the UKOSS Study.
Thank you for your help.